Categories: HardwareMedTech
2/3 of patients experience the symptoms of eye misalignment, but relief is in sight with Neurolens using the NMD2 and Neurolenses with Contoured Prism.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.09.2022 | - | $67M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 30.04.2024 | Neurolenses Proven to Reduce Headache Symptoms | Report highlights the data from the recently published double-masked, randomized Headache Study. Bas... | tullisfund... |
| 16.04.2024 | Neurolens + The Chris Wolfe Podcast | Dr. Chris Wolfe and Davis Corley 6-part podcast series
April 16, 2024 12:04:15 PM by Neurolens Marke... | tullisfund... |
| 13.03.2024 | Neurolens Strengthens Leadership for Accelerated Growth and ... | Coppell, Texas — On a mission to transform eye care, Neurolens is pleased to announce a strategic le... | tullisfund... |
| 04.03.2024 | Neurolenses Demonstrate Significant Headache Relief | A double-masked, randomized, cross-over clinical study shows that patients wearing Neurolenses had i... | tullisfund... |
| 28.09.2023 | Neurolens Introduces N3 | An immersive, virtual-reality-based measurement and education experience | tullisfund... |
| 20.04.2023 | Neurolens Measures Its One Millionth Patient | DALLAS, April 20, 2023 – Neurolens, a company commercializing innovative solutions to optimize visio... | tullisfund... |
| 12.09.2022 | Neurolens Raises $67M in Funding | Neurolens, a Dallas, TX-based company company commercializing innovative solutions to optimize visio... | finsmes.co... |
| 12.09.2022 | Neurolens Raises $67 Million from MVM Partners, Falcon Visio... | Investment will be used to develop new products and drive adoption | tullisfund... |
Reviews 0
